In summary, lycopene’s multifaceted role in combating obesity-related metabolic disorders is supported by its ability to reduce oxidative stress, inflammation, and lipid accumulation while improving glucose metabolism and insulin sensitivity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.